Premier Alternatives

Silver Creek Pharmaceuticals

South San Francisco, CA · Founded 2010 · Privately Held (backing)

Operator of a biotechnology firm intended to develop therapies that improve the body's healing response and repair damaged tissue. Silver Creek Pharmaceuticals is based in South San Francisco, CA and was founded in 2010. Its last reported valuation was $60 million in Feb 2018. It has raised $57.1 million across 2 recorded rounds; the latest was a $9.2 million early-stage round in Jan 2022.

Last reported valuation
$60.0M
Oct 2026
Priced at
—
Total raised
$57.1M
Last round
Early Stage VC
Jan 2022

Silver Creek Pharmaceuticals key facts

as of Oct 2026
  • Operator of a biotechnology firm intended to develop therapies that improve the body's healing response and repair damaged tissue.
  • Silver Creek Pharmaceuticals is valued at approximately $60.0M as of Oct 2026 (last reported valuation).
  • It has raised $57.1M across 2 recorded rounds; the latest was Early Stage VC ($9.2M) in Jan 2022.
  • Notable investors include Catalytik Group, Crocker Ventures, Lung, Mark Agne, National Heart — 8 tracked in total.
  • Silver Creek Pharmaceuticals has filed 2 Form Ds with the SEC since 2016, most recently Feb 2022 ($9.2M sold to 22 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$60.0M

Silver Creek Pharmaceuticals's last reported valuation, Feb 2018. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of Silver Creek Pharmaceuticals with a free account
  • ·Watch Silver Creek Pharmaceuticals: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Silver Creek Pharmaceuticals funding rounds

2 rounds
Jan 2022Early Stage VC$9.2MSEC filing▮
Dec 2016Seed Round$3.4MSEC filing▮
Full funding history →

Silver Creek Pharmaceuticals valuation

Silver Creek Pharmaceuticals's last reported valuation was $60 million in Feb 2018. No priced round, secondary trade or fund mark has surfaced since.

How much has Silver Creek Pharmaceuticals raised?

Silver Creek Pharmaceuticals has raised $57.1 million in total; 2 of its rounds are on record. The largest on record was a $9.2 million early-stage round in Jan 2022.

Silver Creek Pharmaceuticals has filed 2 Form Ds with the SEC since 2016, most recently in Feb 2022 ($9.2 million sold to 22 investors).

Silver Creek Pharmaceuticals investors

8 investors are on record for Silver Creek Pharmaceuticals, including Catalytik Group, Crocker Ventures, Lung and Mark Agne. The early-stage round in Jan 2022 drew 22 investors.

About Silver Creek Pharmaceuticals

Operator of a biotechnology firm intended to develop therapies that improve the body's healing response and repair damaged tissue. The company offers novel regenerative medicines that stimulate stem cell-based regeneration of cardiovascular tissues after a cardiac infarction, providing patients with the required therapies to protect or repair heart tissue following a heart attack.

Sector
Healthcare
HQ
South San Francisco, CA, United States
Founded
2010
Employees
8
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.